InsiderTrades.com logo

Francisco Silva Biography and Net Worth

VP of BioRestorative Therapies
  • Phone
  • Email
  • Website


Secretary, Director & VP-Research & Development

What is Francisco Silva's net worth?

The estimated net worth of Francisco Silva is at least $269,977.79 as of April 8th, 2024. Mr. Silva owns 149,159 shares of BioRestorative Therapies stock worth more than $269,978 as of March 29th. This net worth approximation does not reflect any other assets that Mr. Silva may own. Additionally, Mr. Silva receives a salary of $891,670.00 as VP at BioRestorative Therapies. Learn More about Francisco Silva's net worth.

How old is Francisco Silva?

Mr. Silva is currently 49 years old. There are 3 older executives and no younger executives at BioRestorative Therapies. The oldest executive at BioRestorative Therapies is Mr. Robert Eugene Kristal, Chief Financial Officer, who is 56 years old. Learn More on Francisco Silva's age.

What is Francisco Silva's salary?

As the VP of BioRestorative Therapies, Inc., Mr. Silva earns $891,670.00 per year. The highest earning executive at BioRestorative Therapies is Mr. Lance Alstodt, Chairman of the Board, President & CEO, who commands a salary of $954,170.00 per year. Learn More on Francisco Silva's salary.

How do I contact Francisco Silva?

The corporate mailing address for Mr. Silva and other BioRestorative Therapies executives is 40 MARCUS DRIVE, MELVILLE NY, 11747. BioRestorative Therapies can also be reached via phone at (631) 760-8100 and via email at ir@biorestorative.com. Learn More on Francisco Silva's contact information.

Has Francisco Silva been buying or selling shares of BioRestorative Therapies?

Francisco Silva has not been actively trading shares of BioRestorative Therapies over the course of the past ninety days. Most recently, on Friday, March 31st, Francisco Silva bought 747 shares of BioRestorative Therapies stock. The stock was acquired at an average cost of $3.56 per share, with a total value of $2,659.32. Following the completion of the transaction, the vice president now directly owns 159,690 shares of the company's stock, valued at $568,496.40. Learn More on Francisco Silva's trading history.

Who are BioRestorative Therapies' active insiders?

BioRestorative Therapies' insider roster includes Lance Alstodt (CEO), and Francisco Silva (VP). Learn More on BioRestorative Therapies' active insiders.

Francisco Silva Insider Trading History at BioRestorative Therapies

See Full Table

Francisco Silva Buying and Selling Activity at BioRestorative Therapies

This chart shows Francisco Silva's buying and selling at BioRestorative Therapies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10k$0$10kTotal Insider BuyingTotal Insider Selling

BioRestorative Therapies Company Overview

BioRestorative Therapies logo
BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.
Read More

Today's Range

Now: $1.81
Low: $1.77
High: $1.84

50 Day Range

MA: $1.97
Low: $1.43
High: $2.49

2 Week Range

Now: $1.81
Low: $1.03
High: $2.55

Volume

21,475 shs

Average Volume

405,635 shs

Market Capitalization

$12.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

64.37